TAL1-mediated epigenetic modifications down-regulate the expression of GIMAP family in non-small cell lung cancer
Zhongxiang TangiD, Lili WangiD, Pei Dai, Pinglang RuaniD, Dan Liu, Yurong TaniD
Abstract
BackgroudThe study was designed to explore the role of GIMAP family in non-small cell lung cancer (NSCLC) and its possible expression regulation mechanisms using existing biological databases including encyclopedia of DNA elements (ENCODE), gene expression omnibus (GEO), and the cancer genome atlas (TCGA).\n\nMethodsLung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) were used to evaluate the expression of GIMAPs in TCGA. Five NSCLC datasets were then selected from GEO for validation. RNA-seq and Chip-seq data from ENCODE and GEO were used to observe epigenetic modifications on the chromosomes of GIAMPs in NSCLC. We constructed protein-protein interaction (PPI) network to reveal the main interacting proteins of GIMAPs. We then analyzed the correlation and regulatory mechanism between TAL1 and the expression of GIMAP family. We also used Kaplan-Meier for survival analysis.\n\nResultsAll 7 genes in the GIMAP family were down-regulated in NSCLC. H3K4me3 and H3K27ac disappeared, while H3K27me3 increased on the chromosome of this family. The expression of TAL1 was positively correlated with the expression of GIMAPs. sh-TAL1 significantly down-regulated the expression of GIMAP family through epigenetic modification. High expression of GIMAPs and TAL1 was found to be associated with a good prognosis of NLCSC.\n\nConclusionThe downregulation of TAL1 caused the disappearance of H3K27ac and H3K4me3. It also caused an increase in H3K27me3 on the GIMAPs gene, eventually leading to the overall downregulation of the GIMAP family genes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small cell lung cancer
K. Tsuchiya, K. Yoshimura, … H. Sugimura·Cancer Gene TherapyPeer-reviewed·Mar 22, 2022
- Huntingtin Interacting Protein-1 expression is regulated via HIF2 axis in Lung Adenocarcinoma
P. Prasad, J. Chongtham, … T. Srivastava·bioRxiv·Mar 27, 2023
- LIMD1 Loss as an Early Driver of PD-L1 Upregulation and Immune Evasion in Lung Cancer
Kunal M. Shah, Paul T. Kennedy, … Tyson V. Sharp·bioRxiv·Feb 6, 2025
- SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cells
Christiane Kuempers, Karina Stein, … Torsten Goldmann·bioRxiv·Jul 16, 2026
- YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
Federica Lo Sardo, Claudio Pulito, … Giovanni Blandino·bioRxiv·Jul 10, 2020
- Genome-Wide Epigenomic Profiling of Primary Non-Small Cell Lung Cancer Reveals Specific and Recurrent DNA Methylation Alterations in Smoker Versus Never-Smoker Patients
J. A. Karlow, E. C. Pehrsson, … T. Wang·bioRxiv·Oct 6, 2022